ALK and T-cell non-Hodgkin lymphoma: In this study, we abrogated tumorigenesis in an NPM-ALK–driven T-cell lymphoma model by conditionally targeting the DNA methyltransferase Dnmt1 by Cd4-Cre induced deletion.